世界の第VIII因子欠乏症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Factor VIII Deficiency Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2310
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、128ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、第VIII因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・第VIII因子欠乏症治療の市場動向
・企業の競争状況、市場シェア
・第VIII因子欠乏症治療の種類別市場規模（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）
・第VIII因子欠乏症治療の用途別市場規模（病院、クリニック、その他）
・第VIII因子欠乏症治療の北米市場規模2016-2027（アメリカ、カナダ）
・第VIII因子欠乏症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・第VIII因子欠乏症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・第VIII因子欠乏症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・第VIII因子欠乏症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Takeda、Bayer HealthCare、CSL、Grifols、Novo Nordisk、F. Hoffmann-La Roche、Kedrion、Octapharma、Biogen Idec、BioMarin Pharmaceutical、Sangamo Therapeutics、Spark Therapeutics、Swedish Orphan Biovitrum、Uniqure NV、Amarna Therapeutics、Dimension Therapeutics）
・結論

Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endothelial cells outside the liver across the body. This protein mixes in the bloodstream in an inactive form, and binds to another molecule called von Willebrand factor, until a damage to blood vessels occur. In response to injury, coagulation factor VIII gets activated and separates from von Willebrand factor.
The global hemophilia A drugs market segment accounted for the majority market share and will continue to dominate the factor 8 deficiency treatment market for the next few years. Some of the major factors responsible for the market segment’s growth is the growing incidence of hemophilia A, the development of novel drugs with extended action, and the increased adoption of prophylactic treatment. Additionally, growing demand for novel recombinant extended half-life products, the emergence of monoclonal antibodies and gene therapy products, and launch of plasma-derived products for recombinant factor VIII at low costs, will also further drive the growth of the factor VIII deficiency treatment market.

Market Analysis and Insights: Global Factor VIII Deficiency Treatment Market
The global Factor VIII Deficiency Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Factor VIII Deficiency Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Factor VIII Deficiency Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Factor VIII Deficiency Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Factor VIII Deficiency Treatment market.

Global Factor VIII Deficiency Treatment Scope and Market Size
Factor VIII Deficiency Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Factor VIII Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hemophilia A Drugs
Hemophilia A Inhibitors Treatment
Von Willebrand Disease Treatment

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Takeda
Bayer HealthCare
CSL
Grifols
Novo Nordisk
F. Hoffmann-La Roche
Kedrion
Octapharma
CSL
Grifols
Sangamo Therapeutics
Spark Therapeutics
Swedish Orphan Biovitrum
Uniqure NV

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hemophilia A Drugs
1.2.3 Hemophilia A Inhibitors Treatment
1.2.4 Von Willebrand Disease Treatment
1.3 Market by Application
1.3.1 Global Factor VIII Deficiency Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Factor VIII Deficiency Treatment Market Perspective (2016-2027)
2.2 Factor VIII Deficiency Treatment Growth Trends by Regions
2.2.1 Factor VIII Deficiency Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Factor VIII Deficiency Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Factor VIII Deficiency Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Factor VIII Deficiency Treatment Industry Dynamic
2.3.1 Factor VIII Deficiency Treatment Market Trends
2.3.2 Factor VIII Deficiency Treatment Market Drivers
2.3.3 Factor VIII Deficiency Treatment Market Challenges
2.3.4 Factor VIII Deficiency Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Factor VIII Deficiency Treatment Players by Revenue
3.1.1 Global Top Factor VIII Deficiency Treatment Players by Revenue (2016-2021)
3.1.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Factor VIII Deficiency Treatment Revenue
3.4 Global Factor VIII Deficiency Treatment Market Concentration Ratio
3.4.1 Global Factor VIII Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Factor VIII Deficiency Treatment Revenue in 2020
3.5 Factor VIII Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Factor VIII Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Factor VIII Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Factor VIII Deficiency Treatment Breakdown Data by Type
4.1 Global Factor VIII Deficiency Treatment Historic Market Size by Type (2016-2021)
4.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2022-2027)

5 Factor VIII Deficiency Treatment Breakdown Data by Application
5.1 Global Factor VIII Deficiency Treatment Historic Market Size by Application (2016-2021)
5.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Factor VIII Deficiency Treatment Market Size (2016-2027)
6.2 North America Factor VIII Deficiency Treatment Market Size by Type
6.2.1 North America Factor VIII Deficiency Treatment Market Size by Type (2016-2021)
6.2.2 North America Factor VIII Deficiency Treatment Market Size by Type (2022-2027)
6.2.3 North America Factor VIII Deficiency Treatment Market Size by Type (2016-2027)
6.3 North America Factor VIII Deficiency Treatment Market Size by Application
6.3.1 North America Factor VIII Deficiency Treatment Market Size by Application (2016-2021)
6.3.2 North America Factor VIII Deficiency Treatment Market Size by Application (2022-2027)
6.3.3 North America Factor VIII Deficiency Treatment Market Size by Application (2016-2027)
6.4 North America Factor VIII Deficiency Treatment Market Size by Country
6.4.1 North America Factor VIII Deficiency Treatment Market Size by Country (2016-2021)
6.4.2 North America Factor VIII Deficiency Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Factor VIII Deficiency Treatment Market Size (2016-2027)
7.2 Europe Factor VIII Deficiency Treatment Market Size by Type
7.2.1 Europe Factor VIII Deficiency Treatment Market Size by Type (2016-2021)
7.2.2 Europe Factor VIII Deficiency Treatment Market Size by Type (2022-2027)
7.2.3 Europe Factor VIII Deficiency Treatment Market Size by Type (2016-2027)
7.3 Europe Factor VIII Deficiency Treatment Market Size by Application
7.3.1 Europe Factor VIII Deficiency Treatment Market Size by Application (2016-2021)
7.3.2 Europe Factor VIII Deficiency Treatment Market Size by Application (2022-2027)
7.3.3 Europe Factor VIII Deficiency Treatment Market Size by Application (2016-2027)
7.4 Europe Factor VIII Deficiency Treatment Market Size by Country
7.4.1 Europe Factor VIII Deficiency Treatment Market Size by Country (2016-2021)
7.4.2 Europe Factor VIII Deficiency Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size (2016-2027)
8.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type
8.2.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application
8.3.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region
8.4.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Factor VIII Deficiency Treatment Market Size (2016-2027)
9.2 Latin America Factor VIII Deficiency Treatment Market Size by Type
9.2.1 Latin America Factor VIII Deficiency Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Factor VIII Deficiency Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Factor VIII Deficiency Treatment Market Size by Type (2016-2027)
9.3 Latin America Factor VIII Deficiency Treatment Market Size by Application
9.3.1 Latin America Factor VIII Deficiency Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Factor VIII Deficiency Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Factor VIII Deficiency Treatment Market Size by Application (2016-2027)
9.4 Latin America Factor VIII Deficiency Treatment Market Size by Country
9.4.1 Latin America Factor VIII Deficiency Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Factor VIII Deficiency Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size (2016-2027)
10.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type
10.2.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application
10.3.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country
10.4.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Factor VIII Deficiency Treatment Introduction
11.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Factor VIII Deficiency Treatment Introduction
11.2.4 Takeda Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.2.5 Takeda Recent Development
11.3 Bayer HealthCare
11.3.1 Bayer HealthCare Company Details
11.3.2 Bayer HealthCare Business Overview
11.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Introduction
11.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.3.5 Bayer HealthCare Recent Development
11.4 CSL
11.4.1 CSL Company Details
11.4.2 CSL Business Overview
11.4.3 CSL Factor VIII Deficiency Treatment Introduction
11.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.4.5 CSL Recent Development
11.5 Grifols
11.5.1 Grifols Company Details
11.5.2 Grifols Business Overview
11.5.3 Grifols Factor VIII Deficiency Treatment Introduction
11.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.5.5 Grifols Recent Development
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Details
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Factor VIII Deficiency Treatment Introduction
11.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.6.5 Novo Nordisk Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Kedrion
11.8.1 Kedrion Company Details
11.8.2 Kedrion Business Overview
11.8.3 Kedrion Factor VIII Deficiency Treatment Introduction
11.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.8.5 Kedrion Recent Development
11.9 Octapharma
11.9.1 Octapharma Company Details
11.9.2 Octapharma Business Overview
11.9.3 Octapharma Factor VIII Deficiency Treatment Introduction
11.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.9.5 Octapharma Recent Development
11.10 Biogen Idec
11.10.1 Biogen Idec Company Details
11.10.2 Biogen Idec Business Overview
11.10.3 Biogen Idec Factor VIII Deficiency Treatment Introduction
11.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.10.5 Biogen Idec Recent Development
11.11 BioMarin Pharmaceutical
11.11.1 BioMarin Pharmaceutical Company Details
11.11.2 BioMarin Pharmaceutical Business Overview
11.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Introduction
11.11.4 BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.11.5 BioMarin Pharmaceutical Recent Development
11.12 Sangamo Therapeutics
11.12.1 Sangamo Therapeutics Company Details
11.12.2 Sangamo Therapeutics Business Overview
11.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Introduction
11.12.4 Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.12.5 Sangamo Therapeutics Recent Development
11.13 Spark Therapeutics
11.13.1 Spark Therapeutics Company Details
11.13.2 Spark Therapeutics Business Overview
11.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Introduction
11.13.4 Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.13.5 Spark Therapeutics Recent Development
11.14 Swedish Orphan Biovitrum
11.14.1 Swedish Orphan Biovitrum Company Details
11.14.2 Swedish Orphan Biovitrum Business Overview
11.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Introduction
11.14.4 Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.14.5 Swedish Orphan Biovitrum Recent Development
11.15 Uniqure NV
11.15.1 Uniqure NV Company Details
11.15.2 Uniqure NV Business Overview
11.15.3 Uniqure NV Factor VIII Deficiency Treatment Introduction
11.15.4 Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.15.5 Uniqure NV Recent Development
11.16 Amarna Therapeutics
11.16.1 Amarna Therapeutics Company Details
11.16.2 Amarna Therapeutics Business Overview
11.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Introduction
11.16.4 Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.16.5 Amarna Therapeutics Recent Development
11.17 Dimension Therapeutics
11.17.1 Dimension Therapeutics Company Details
11.17.2 Dimension Therapeutics Business Overview
11.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Introduction
11.17.4 Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2016-2021)
11.17.5 Dimension Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hemophilia A Drugs
Table 3. Key Players of Hemophilia A Inhibitors Treatment
Table 4. Key Players of Von Willebrand Disease Treatment
Table 5. Global Factor VIII Deficiency Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Factor VIII Deficiency Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Factor VIII Deficiency Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Factor VIII Deficiency Treatment Market Share by Regions (2016-2021)
Table 9. Global Factor VIII Deficiency Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Factor VIII Deficiency Treatment Market Share by Regions (2022-2027)
Table 11. Factor VIII Deficiency Treatment Market Trends
Table 12. Factor VIII Deficiency Treatment Market Drivers
Table 13. Factor VIII Deficiency Treatment Market Challenges
Table 14. Factor VIII Deficiency Treatment Market Restraints
Table 15. Global Factor VIII Deficiency Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Factor VIII Deficiency Treatment Market Share by Players (2016-2021)
Table 17. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Factor VIII Deficiency Treatment as of 2020)
Table 18. Ranking of Global Top Factor VIII Deficiency Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Factor VIII Deficiency Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Factor VIII Deficiency Treatment Product Solution and Service
Table 22. Date of Enter into Factor VIII Deficiency Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Factor VIII Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Factor VIII Deficiency Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Factor VIII Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Factor VIII Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Factor VIII Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Factor VIII Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Factor VIII Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Factor VIII Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Factor VIII Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Factor VIII Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Factor VIII Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Factor VIII Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Factor VIII Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Factor VIII Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Factor VIII Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Factor VIII Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Factor VIII Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Factor VIII Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Factor VIII Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Factor VIII Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Factor VIII Deficiency Treatment Product
Table 65. Pfizer Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Takeda Company Details
Table 68. Takeda Business Overview
Table 69. Takeda Factor VIII Deficiency Treatment Product
Table 70. Takeda Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 71. Takeda Recent Development
Table 72. Bayer HealthCare Company Details
Table 73. Bayer HealthCare Business Overview
Table 74. Bayer HealthCare Factor VIII Deficiency Treatment Product
Table 75. Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 76. Bayer HealthCare Recent Development
Table 77. CSL Company Details
Table 78. CSL Business Overview
Table 79. CSL Factor VIII Deficiency Treatment Product
Table 80. CSL Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 81. CSL Recent Development
Table 82. Grifols Company Details
Table 83. Grifols Business Overview
Table 84. Grifols Factor VIII Deficiency Treatment Product
Table 85. Grifols Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 86. Grifols Recent Development
Table 87. Novo Nordisk Company Details
Table 88. Novo Nordisk Business Overview
Table 89. Novo Nordisk Factor VIII Deficiency Treatment Product
Table 90. Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 91. Novo Nordisk Recent Development
Table 92. F. Hoffmann-La Roche Company Details
Table 93. F. Hoffmann-La Roche Business Overview
Table 94. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product
Table 95. F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 96. F. Hoffmann-La Roche Recent Development
Table 97. Kedrion Company Details
Table 98. Kedrion Business Overview
Table 99. Kedrion Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 100. Kedrion Recent Development
Table 101. Octapharma Company Details
Table 102. Octapharma Business Overview
Table 103. Octapharma Factor VIII Deficiency Treatment Product
Table 104. Octapharma Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 105. Octapharma Recent Development
Table 106. Biogen Idec Company Details
Table 107. Biogen Idec Business Overview
Table 108. Biogen Idec Factor VIII Deficiency Treatment Product
Table 109. Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 110. Biogen Idec Recent Development
Table 111. BioMarin Pharmaceutical Company Details
Table 112. BioMarin Pharmaceutical Business Overview
Table 113. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product
Table 114. BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 115. BioMarin Pharmaceutical Recent Development
Table 116. Sangamo Therapeutics Company Details
Table 117. Sangamo Therapeutics Business Overview
Table 118. Sangamo Therapeutics Factor VIII Deficiency Treatment Product
Table 119. Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 120. Sangamo Therapeutics Recent Development
Table 121. Spark Therapeutics Company Details
Table 122. Spark Therapeutics Business Overview
Table 123. Spark Therapeutics Factor VIII Deficiency Treatment Product
Table 124. Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 125. Spark Therapeutics Recent Development
Table 126. Swedish Orphan Biovitrum Company Details
Table 127. Swedish Orphan Biovitrum Business Overview
Table 128. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product
Table 129. Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 130. Swedish Orphan Biovitrum Recent Development
Table 131. Uniqure NV Company Details
Table 132. Uniqure NV Business Overview
Table 133. Uniqure NV Factor VIII Deficiency Treatment Product
Table 134. Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 135. Uniqure NV Recent Development
Table 136. Amarna Therapeutics Company Details
Table 137. Amarna Therapeutics Business Overview
Table 138. Amarna Therapeutics Factor VIII Deficiency Treatment Product
Table 139. Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 140. Amarna Therapeutics Recent Development
Table 141. Dimension Therapeutics Company Details
Table 142. Dimension Therapeutics Business Overview
Table 143. Dimension Therapeutics Factor VIII Deficiency Treatment Product
Table 144. Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 145. Dimension Therapeutics Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Factor VIII Deficiency Treatment Market Share by Type: 2020 VS 2027
Figure 2. Hemophilia A Drugs Features
Figure 3. Hemophilia A Inhibitors Treatment Features
Figure 4. Von Willebrand Disease Treatment Features
Figure 5. Global Factor VIII Deficiency Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Factor VIII Deficiency Treatment Report Years Considered
Figure 10. Global Factor VIII Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Factor VIII Deficiency Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Factor VIII Deficiency Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Factor VIII Deficiency Treatment Market Share by Regions (2022-2027)
Figure 14. Global Factor VIII Deficiency Treatment Market Share by Players in 2020
Figure 15. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Factor VIII Deficiency Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Factor VIII Deficiency Treatment Revenue in 2020
Figure 17. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Factor VIII Deficiency Treatment Market Share by Type (2016-2027)
Figure 21. North America Factor VIII Deficiency Treatment Market Share by Application (2016-2027)
Figure 22. North America Factor VIII Deficiency Treatment Market Share by Country (2016-2027)
Figure 23. United States Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Factor VIII Deficiency Treatment Market Share by Type (2016-2027)
Figure 27. Europe Factor VIII Deficiency Treatment Market Share by Application (2016-2027)
Figure 28. Europe Factor VIII Deficiency Treatment Market Share by Country (2016-2027)
Figure 29. Germany Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Factor VIII Deficiency Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Factor VIII Deficiency Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Factor VIII Deficiency Treatment Market Share by Region (2016-2027)
Figure 39. China Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Factor VIII Deficiency Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Factor VIII Deficiency Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Factor VIII Deficiency Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Factor VIII Deficiency Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Factor VIII Deficiency Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Factor VIII Deficiency Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Factor VIII Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 59. Takeda Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 60. Bayer HealthCare Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 61. CSL Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 62. Grifols Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 63. Novo Nordisk Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 64. F. Hoffmann-La Roche Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 65. Kedrion Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 66. Octapharma Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 67. Biogen Idec Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 68. BioMarin Pharmaceutical Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 69. Sangamo Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 70. Spark Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 71. Swedish Orphan Biovitrum Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 72. Uniqure NV Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 73. Amarna Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 74. Dimension Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

以下、関連資料のご紹介

世界の第VIII因子欠乏症治療市場 2021：企業別、地域別、種類・用途別

Global Factor VIII Deficiency Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z05433 2021年4月 123Pages
当調査資料では、第VIII因子欠乏症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。第VIII因子欠乏症治療の種類別市場規模（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米...

世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2309 2021年4月 97Pages
QYResearch社発行の本調査資料では、第IX因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病B、血友病B阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の第IX因子欠乏症治療市場 2021：企業別、地域別、種類・用途別

Global Factor IX Deficiency Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z05432 2021年4月 100Pages
当調査資料では、第IX因子欠乏症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。第IX因子欠乏症治療の種類別市場規模（血友病B、血友病B阻害剤）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のビタミンD欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Vitamin D Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5957 2021年4月 92Pages
QYResearch社発行の本調査資料では、ビタミンD欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビタミンD2、ビタミンD3）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界のアルファ-アンチトリプシン欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0255 2021年4月 133Pages
QYResearch社発行の本調査資料では、アルファ-アンチトリプシン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CT-2009、POL-6014、ARO-AAT、ALNAAT-02、その他）、用途別市場規模（クリニック、病院、そ...

世界の成長ホルモン欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Growth Hormone Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2639 2021年4月 90Pages
QYResearch社発行の本調査資料では、成長ホルモン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、組換えヒト成長ホルモン、ヒト下垂体抽出物、手術）、用途別市場規模（病院、診療所、在宅ケア）、主要地域別市場規模（北米、ア...

世界のチロシンヒドロキシラーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Tyrosine Hydroxylase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5773 2021年4月 91Pages
QYResearch社発行の本調査資料では、チロシンヒドロキシラーゼ欠損症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（投薬、言語療法、その他）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のCARD9欠乏症治療市場規模・現状・予測（2021年-2027年）

Global CARD9 Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1109 2021年4月 96Pages
QYResearch社発行の本調査資料では、CARD9欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（全身性抗真菌性感染症、表面的抗真菌性感染症）、用途別市場規模（病院、クリニック、薬局、その他）、主要地域別市場規模（北米、アメリカ、...

世界のCARD9欠乏症治療市場規模・現状・予測（2021年-2027年）

世界の第VIII因子欠乏症治療市場 2021：企業別、地域別、種類・用途別 The Factor VIII Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…
世界の第IX因子欠乏症治療市場 2021：企業別、地域別、種類・用途別 The Factor IX Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年） ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. Market Analysis and Insights: Global Acquired hemophilia A Treatment Market The global Acquired hemophilia A Treatment market size is projected to reach US$ X…
世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Treatment Market The global Adenosine Deaminase Deficiency Treat…